NPCE 241220 7.50C (NPCE241220C7500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

NPCE241220C7500

Watchlist

0.50
0.000.00%

15min DelayClose Nov 27 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $13
Moomoo NewsNov 22 07:31 ET · Ratings
Strong Buy Recommendation for NeuroPace Amid Promising RNS System Results and Anticipated Market Advancements
TipRanksNov 22 06:35 ET
What Makes NeuroPace (NPCE) a New Buy Stock
Yahoo FinanceNov 18 12:00 ET
NeuroPace, Inc.'s (NASDAQ:NPCE) Shares Leap 42% Yet They're Still Not Telling The Full Story
Simply Wall StNov 14 05:29 ET
NeuroPace Third Quarter 2024 Earnings: Beats Expectations
Yahoo FinanceNov 14 05:23 ET
Neuropace Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Sales Guidance. Wells Fargo Maintained an Overweight Rating on the Stock.
BenzingaNov 13 13:13 ET

Comments

Moomoo AI

Mar 7 13:13

Analysts show improved sentiment towards NeuroPace, upgrading their numbers and reducing losses per share. A wide gap in price targets implies a broad range of business scenarios. NeuroPace is expected to outpace industry growth.

Earnings Update: Here's Why Analysts Just Lifted Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$16.00

Moomoo AI

Feb 8 14:14

NeuroPace's high P/S ratio is justified by expected strong revenue growth, outpacing the Medical Equipment industry. Shareholders are optimistic about future revenues, holding onto their shares.

NeuroPace, Inc.'s (NASDAQ:NPCE) P/S Is Still On The Mark Following 34% Share Price Bounce

Analysts Notebook

Apr 6, 2022 06:01

Columns Top upgrades and downgrades on 4/6

Upgrades
• $Banc of California (BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers (CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger (GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc (INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp (PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...

Rama Krishna Gonga

Sep 22, 2021 06:11

$NeuroPace (NPCE.US)$ So the price action on this really looks like the bull run will take it up.
It recently ipo'd so theres a ton of volume surging through this.
The macd doesnt look to good but it could continue to churn upward.
The vortex5 its about to cross the .75 line and would that be the buy signal?
Will we see institutional buying at these levels?

DisneyDad

Apr 21, 2021 19:50

$NeuroPace (NPCE.US)$ trying to enter below 15 if lucky
IPO’ed today